Quynh-Thu Le

Clinical Trials

• Recruiting Manuka Honey in Preventing Esophagitis-Related Pain in Patients Receiving Chemotherapy and Radiation Therapy For Lung Cancer
• Recruiting Imaging and Biomarkers of Hypoxia in Solid Tumors
• Recruiting Radiation Therapy With Cisplatin, Docetaxel, or Cetuximab After Surgery in Treating Patients With Stage III-IV Squamous Cell Head and Neck Cancer
• Not Recruiting Bevacizumab, Cisplatin, Radiation Therapy, and Fluorouracil in Treating Patients With Stage IIB, Stage III, Stage IVA, or Stage IVB Nasopharyngeal Cancer
• Not Recruiting TRYHARD: Radiation Therapy Plus Cisplatin With or Without Lapatinib in Treating Patients With Head and Neck Cancer.
• Recruiting Novel Serum Markers for Monitoring Response to Anti-Cancer Therapy
• Not Recruiting Chemotherapy and Radiation Therapy (RT) With or Without Vandetanib in Treating Patients With High-Risk Stage III or Stage IV Head and Neck Cancer
• Recruiting Identification of Secreted Markers for Tumor Hypoxia in Patients With Head and Neck or Lung Cancers
• Recruiting Identification and Characterization of Novel Proteins and Genes in Head and Neck Cancer
• Recruiting Radiation Therapy, Paclitaxel, and Carboplatin With or Without Trastuzumab in Treating Patients With Esophageal Cancer
• Recruiting Radiation Therapy With Cisplatin or Cetuximab in Treating Patients With Oropharyngeal Cancer
• Recruiting Radiation Therapy With or Without Chemotherapy in Treating Patients With High-Risk Malignant Salivary Gland Tumors That Have Been Removed By Surgery
• Recruiting Radiation Therapy With or Without Cetuximab in Treating Patients Who Have Undergone Surgery for Locally Advanced Head and Neck Cancer
• Recruiting Feasibility of IMRT Modulation to Account for Scattered Radiation From Dental Fillings in Head and Neck Cancer
• Recruiting Phase II Sequential and Concurrent Chemoradiation for Advanced Nasopharyngeal Carcinoma (NPC)
• Recruiting Image-Guided Radiosurgery or Stereotactic Body Radiation Therapy in Treating Patients With Localized Spine Metastasis
• Recruiting Chemotherapy and Radiation Therapy With or Without Panitumumab in Treating Patients With Stage IIIA Non-Small Cell Lung Cancer (Cetuximab Closed as of 05/14/10)
• Recruiting Trial of Individualized Lung Tumor Stereotactic Ablative Radiotherapy (SABR)
• Not Recruiting CyberKnife Radiosurgical Treatment of Inoperable Early Stage Non-Small Cell Lung Cancer
• Not Recruiting Surgery With or Without Internal Radiation Therapy Compared With Stereotactic Body Radiation Therapy in Treating Patients With High-Risk Stage I Non-Small Cell Lung Cancer
• Not Recruiting Radiation Therapy and Cisplatin With or Without Cetuximab in Treating Patients With Stage III or Stage IV Head and Neck Cancer
• Not Recruiting Palifermin for the Reduction of Oral Mucositis in Subjects With Locally Advanced Head and Neck Cancer
• Not Recruiting Treatment Outcomes and Quality of Life After IMRT Treatments of Head and Neck Cancers
• Not Recruiting Indirect Magnetic Resonance Lymphangiography of the Head and Neck Region Using Conventional Gadolinium-based Contrast
• Not Recruiting Cervical Nodal Mets in Squamous Cell Carcinoma of H&N - MRI, FDG-PET, & Histopathologic Correlation
• Not Recruiting Real-Time kV Imaging vs. Real-Time 3D Patient Surface Tracking for Head & Neck Cancer
• Not Recruiting Phase II Docetaxel / Carboplatin / XRT + Surgical Resection in Stage III NSCLC
• Not Recruiting Evaluation of Cyberknife Precision Radiation Delivery System for Unresectable Malignant Lung Cancer
• Not Recruiting Pulmonary Interstitial Lymphography in Early Stage Lung Cancer
• Not Recruiting Endoscopic Capillary Oximetry for Tumor Diagnosis in Head and Neck Cancer
• Not Recruiting Cyberknife Radiosurgery for Locally Advanced Pancreatic Cancer
• Not Recruiting Cisplatin and ZD1839 + Re-Irradiation in Recurrent Squamous Cell Cancer of the Head and Neck
• Not Recruiting The Role of FDG PET in Radiation Treatment Planning for Head and Neck Cancers
• Not Recruiting Identification of Serum Markers For Tumor Hypoxia in Non-Small Cell Lung Cancers
• Not Recruiting Radiation Therapy in Preventing CNS Metastases in Patients With Non-Small Cell Lung Cancer
• Not Recruiting Study to Assess Safety and Tolerability of AG013 in Oral Mucositis in Subjects Receiving Induction Chemotherapy for the Treatment of Cancers of the Head and Neck
• Not Recruiting Paclitaxel, Cisplatin, and Cetuximab Followed By Cetuximab and Intensity-Modulated Radiation Therapy in Treating Patients With HPV-Associated Stage III or Stage IV Cancer of the Oropharynx That Can Be Removed By Surgery
• Not Recruiting Phase II Lapatinib and Radiation for Stage III-IV Head and Neck Cancer Patients Who Cannot Tolerate Concurrent Chemotherapy
• Not Recruiting Memantine in Preventing Side Effects in Patients Undergoing Whole-Brain Radiation Therapy for Brain Metastases From Solid Tumors
• Not Recruiting Avoiding the Hippocampus During Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases
• Not Recruiting Biopsy of Human Tumors for Cancer Stem Cell Characterization: a Feasibility Study
• Recruiting Radiation Therapy in Treating Patients With Extensive Stage Small Cell Lung Cancer
• Recruiting A Longitudinal Study of Plasma EBV DNA in Nasopharyngeal Carcinoma From Both Endemic and Non-Endemic Patient Populations
• Recruiting Phase I Trial of Metabolic Reprogramming Therapy for Treatment of Recurrent Head and Neck Cancers